Information Provided By: 
Fly News Breaks for April 9, 2018
REGN
Apr 9, 2018 | 08:51 EDT
As previously reported, Raymond James downgraded Regeneron to Market Perform from Outperform. Analyst Laura Chico said Regeneron has one of biotech's broadest pipelines, but is challenged to find late-stage opportunities that are not fully reflected in valuation. Chico said as Elyea matures, it is challenging to justify a premium multiple and recommends moving to the sidelines given limited opportunities near-term to move shares higher.
News For REGN From the Last 2 Days
There are no results for your query REGN
